The poster titled “Short term prediction of Atrial Fibrillation from ambulatory ECG using deep learning” presents results of a clinical study demonstrating that Cardiologs’ AI algorithm can predict the short-term risk of atrial fibrillation (AFib) based on single-lead Ambulatory electrocardiograms (ECGs) that show normal sinus rhythm.
News | Atrial Fibrillation
Cardiologs Announces Poster Presentation at ACC 2022

April 1, 2022 — Cardiologs announced a poster presentation at the 2022 American College of Cardiology (ACC) meeting in ...

Home April 01, 2022
Home
Philips Ambient Experience with FlexVision display for pediatric patients
News | ACC
Philips Adds to its Cardiology Suite of Solutions at ACC 2022

April 1, 2022 — Royal Philips, a global leader in health technology, announced new additions to its innovative ...

Home April 01, 2022
Home
Screen Shot 2022-02-11 at 10.29.50 AM_0
News | ACC
Aidoc Showcases Full Cardiovascular AI Care Coordination Suite at ACC.22
March 31, 2022 – Healthcare AI solutions provider Aidoc will be delivering a live demonstration of its comprehensive AI ...
Home March 31, 2022
Home
800_gettyimages-1318375532
News | ACC
ACC Scientific Session 2022 to Feature Smidt Heart Institute Experts
March 31, 2022 – Experts from the Smidt Heart Institute at Cedars-Sinai, home to California’s top-ranked cardiology and ...
Home March 31, 2022
Home
CathWorks_PressReleaseCard__V2
News | ACC
CathWorks Presents New Data and Latest Innovations at ACC 2022
March 31, 2022 – CathWorks has announced that the results of its most recent outcomes study on the CathWorks FFRangio ...
Home March 31, 2022
Home
In accordance with its commitment to patient safety, Medtronic recently voluntarily recalled a subset of its IN.PACT Admiral and IN.PACT AV Paclitaxel-coated Percutaneous Transluminal Angioplasty (PTA) balloon catheters due to the potential for pouch damage resulting in a loss of sterility.
News | Drug-Eluting Balloons
Medtronic Issues Voluntary Recall for Subset of IN.PACT Admiral and IN.PACT AV Drug Coated Balloon

March 31, 2022 — In accordance with its commitment to patient safety, Medtronic recently voluntarily recalled a subset ...

Home March 31, 2022
Home
MedWatch, The FDA Safety Information and Adverse Event Reporting Program, announced that Pfizer is recalling Accuretic (quinapril hydrochloride/hydrochlorothiazide) tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone (quinapril HCL and hydrochlorothiazide and quinapril HCl/hydrochlorothiazide) due to the presence of a nitrosamine, N-nitroso-quinapril, above the Acceptable Daily Intake level.
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
Top 10: Most Read Cardiology Content in March 2022

Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of March ...

Home March 31, 2022
Home
Low-Res_EHJ.jpg
News | Heart Failure
Bone Marrow Contributes to the Development of Atherosclerosis
April 1, 2022 – The activation of the bone marrow appears to play a key role in the origin and development of ...
Home March 31, 2022
Home
Stereotaxis’ Genesis Robotic Magnetic Navigation (RMN) system
News | Robotic Systems
National Institute of Cardiology Becomes First Hospital in Poland to Establish Advanced Robotic Program to Treat Heart Rhythm Disorders
April 1, 2022 – Stereotaxis, the global leader in innovative robotic technologies for the treatment of cardiac ...
Home March 31, 2022
Home
The annual congress of the European Heart Rhythm Association (EHRA), a branch of the ESC, will be held April 3-5 at the Bella Center in Copenhagen, Denmark and online. Explore the scientific program.
News | ESC
EHRA 2022: Cutting Edge Science in Heart Rhythm Disorders

March 31, 2022 — The annual congress of the European Heart Rhythm Association (EHRA), a branch of the ESC, will be held ...

Home March 31, 2022
Home
COVID-19 patient
News | Coronavirus (COVID-19)
International Multi-center Study Confirms Stroke Risk in Younger Healthier COVID-19 Patients
April 1, 2022 – Over the course of the pandemic, a number of studies examined whether COVID-19 patients were at ...
Home March 31, 2022
Home
Study researchers
News | Population Health
Living Near Green Areas Reduces the Risk of Suffering a Stroke by 16%

April 1, 2022 – The risk of suffering an ischemic stroke, the most common type of cerebrovascular event, is 16% less in ...

Home March 31, 2022
Home
Investigators from Cedars-Sinai have created an artificial intelligence-enabled tool that may make it easier to predict if a person will have a heart attack.
News | CT Angiography (CTA)
Artificial Intelligence Tool May Help Predict Heart Attacks

March 31, 2022 – Investigators from Cedars-Sinai have created an artificial intelligence-enabled tool that may make it ...

Home March 31, 2022
Home
DiA Imaging Analysis Ltd, a leading global provider of AI-powered ultrasound analysis software, announced today a multi-year agreement with Change Healthcare, a global industry-leading provider of enterprise imaging solutions.
News | Cardiovascular Ultrasound
DiA Imaging Analysis Teams up with Healthcare Technology Company to Expand its AI Offering for Echo-lab Cardiac Exams
March 31, 2022 – DiA Imaging Analysis Ltd, a leading global provider of AI-powered ultrasound analysis software ...
Home March 31, 2022
Home
Windtree Therapeutics, a biotechnology company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced it has successfully completed enrollment in its phase 2 study of istaroxime in early cardiogenic shock caused by heart failure.
News | Pharmaceuticals
Windtree Completes Enrollment of Phase 2 Study of Istaroxime in Early Cardiogenic Shock
March 31, 2022 – Windtree Therapeutics, a biotechnology company focused on advancing multiple late-stage interventions ...
Home March 31, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now